Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The discovery and development of HMG-CoA reductase inhibitors.

Endo A.

J Lipid Res. 1992 Nov;33(11):1569-82. Review. No abstract available.

2.

Biochemical aspect of HMG CoA reductase inhibitors.

Endo A, Hasumi K.

Adv Enzyme Regul. 1989;28:53-64. Review.

PMID:
2696346
3.

HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.

Aronson JK, Ng LL.

Q J Med. 1990 Feb;74(274):111-5. Review. No abstract available.

PMID:
2111916
4.

Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors.

Sirtori CR.

Pharmacol Ther. 1993 Dec;60(3):431-59. Review.

PMID:
8073070
5.

Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.

Illingworth DR, Bacon S.

Am J Cardiol. 1987 Oct 30;60(12):33G-42G. Review.

PMID:
3314447
6.

[Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].

Carmena R.

Rev Esp Cardiol. 1995 Jan;48(1):59-65. Review. Spanish. No abstract available.

PMID:
7878284
7.
8.

Long-term clinical tolerance of lovastatin and simvastatin.

Bilheimer DW.

Cardiology. 1990;77 Suppl 4:58-65. Review.

PMID:
2073673
9.

Reductase inhibitor therapy of hypercholesterolemia.

Kreisberg RA.

Trans Am Clin Climatol Assoc. 1991;102:153-63; discussion 163-5. Review. No abstract available.

10.

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Tobert JA.

Nat Rev Drug Discov. 2003 Jul;2(7):517-26. Review.

PMID:
12815379
11.

Pravastatin sodium, a new HMG-CoA reductase inhibitor.

Raasch RH.

DICP. 1991 Apr;25(4):388-94. Review.

PMID:
1926908
12.

Hypocholesterolemic agents.

Endo A.

Biotechnology. 1994;26:301-20. Review. No abstract available.

PMID:
7749309
13.

Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.

Davidson MH.

Drugs. 2001;61(2):197-206. Review.

PMID:
11270938
14.

Statin therapy in clinical practice: new developments.

Shepherd J.

Curr Opin Lipidol. 1995 Oct;6(5):254-5. Review. No abstract available.

PMID:
8520846
15.

A review of clinical trials comparing HMG-CoA reductase inhibitors.

Illingworth DR, Tobert JA.

Clin Ther. 1994 May-Jun;16(3):366-85; discussion 365. Review.

PMID:
7923304
16.

Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.

Chong PH, Seeger JD.

Pharmacotherapy. 1997 Nov-Dec;17(6):1157-77. Review.

PMID:
9399600
17.

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.

Plosker GL, Wagstaff AJ.

Drugs. 1996 Mar;51(3):433-59. Review.

PMID:
8882381
18.

Compactin-a review.

Chakravarti R, Sahai V.

Appl Microbiol Biotechnol. 2004 Jun;64(5):618-24. Epub 2004 Mar 19. Review.

PMID:
15034683
19.
20.

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.

Grundy SM.

N Engl J Med. 1988 Jul 7;319(1):24-33. Review. No abstract available.

PMID:
3288867

Supplemental Content

Support Center